CS-206 in Patients With Sickle Cell Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Sickle Cell Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Contact: Study coordinator (Yongrong Lai, M.D.)
Contact: Principal Investigator (Yongrong Lai, M.D.)

Study leads

Yongrong Lai, M.D.
Principal Investigator
First Affiliated Hospital of Guangxi Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

Gene Editing For Sickle Cell Disease

Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE1

Memphis, United States

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Sickle Cell Disease · Thalassemia · Hemoglobinopathy

Abroad (travel likely)RecruitingEARLY_PHASE1

Bethesda, United States

Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease

Sickle Cell · PKLR Variants · Adenosine Triphosphate Activities

Abroad (travel likely)Recruiting

Bethesda, United States